| Brokerage Reports (Showing 1 to 8 of 8) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 17-Nov-09 | Thomson StreetEvents | N/A | GILD - Event Transcript of Gilead Sciences conference call, Nov. 17, 2009 / 2:10pm ET | 10 | $75 | | | View Abstract |
| 12-Nov-09 | Thomson StreetEvents | N/A | GILD - Event Transcript of Gilead Sciences conference call, Nov. 11, 2009 / 10:00am ET | 9 | $75 | | | View Abstract |
| 3-Nov-09 | Thomson StreetEvents | N/A | GILD - Event Transcript of Gilead Sciences conference call, Nov. 03, 2009 / 10:50am ET | 7 | $75 | | | View Abstract |
| 22-Oct-09 | Thomson StreetEvents | N/A | GILD - Event Transcript of Gilead Sciences conference call, Oct. 20, 2009 / 4:30pm ET | 21 | $75 | | | View Abstract |
| 22-Oct-09 | Thomson StreetEvents | N/A | GILD - Event Brief of Gilead Sciences conference call, Oct. 20, 2009 / 4:30pm ET | 23 | $75 | | | View Abstract |
| 22-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Sector Outperform on Amgen Inc. | 12 | $25 | | | View Abstract |
| 21-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global rates Biogen Idec as ST MarketPerform | 13 | $50 | | | View Abstract |
| 21-Oct-09 | First Global | Kavita Thomas, Devina Mehra | First Global reiterates Moderate Outperform on Gilead Sciences | 13 | $50 | | | View Abstract |